Table 5: Outcomes of NVUGIB patients with and without AKI.
|
Unadjusted |
Adjusted1 |
|||||
|
Without AKI |
With AKI |
Odds Ratio for patients with AKI |
p Value |
Odds Ratio for patients with AKI |
p Value |
|
|
Mortality |
2.13% |
10.34% |
5.30 (5.14-5.47) |
< 0.001 |
2.84 (2.71-2.97) |
< 0.001 |
|
Blood Transfusion |
43.78% |
53.96% |
1.63 (1.59-1.68) |
< 0.001 |
1.30 (1.26-1.33) |
< 0.001 |
|
Length of Stay |
4.2 Days |
7.3 Days |
+ 3.10 days (2.99-3.16)3 |
< 0.001 |
+ 1.73 days (1.65-1.80) 3 |
< 0.001 |
|
Hospital Charges |
$27,542 |
$60,997 |
+ $ 33,454 ($ 32,297-$ 34,611)4 |
< 0.001 |
+ $ 16,221 ($ 15,346 -$ 17,096)4 |
< 0.001 |
|
Disposition to Intermediate Care Facility2 |
27.72% |
48.61% |
2.47 (2.42-2.52) |
< 0.001 |
1.84 (1.80-1.89) |
< 0.001 |
1Adjusted for patient demographics, co-morbidities and hospital characteristics.
2Comparing disposition to intermediate care facility to discharge to home. Excluded patients who died or left against medical advice during the hospitalizations.
3Denoted as difference in length of stay in days between patients without AKI and with AKI.
4Denoted as difference in cost of hospitalization between patients without AKI and with AKI.